Jamjoom Pharma (4015)
4015 · Health Care · 
Saudi Arabia
Jamjoom Pharma (4015) is a company in the Health Care sector, based in Saudi Arabia. The stock is held in 1 ETF we track – with its largest weight of 0.01 % in IS3N (msci-em-imi). Anyone holding one of these ETFs also owns a small indirect stake in Jamjoom Pharma.
How many funds hold this stock?
Low ETF coverage: 1 of the 95 ETFs we cover holds Jamjoom Pharma, spread across one index. That places it among the least widely held names in index funds — of the 4,334 stocks we cover, none sits in fewer ETFs.
The line counts the funds we cover, not the market. Dashed: how many funds published a holdings list on that date.
What ETF is Jamjoom Pharma in?
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| IS3N | msci-em-imi | 0.01 % | €0.10 |
The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to Jamjoom Pharma as of the fund's latest holdings list.
Weight in IS3N since 2023
In IS3N, a fund tracking the MSCI EM IMI, Jamjoom Pharma had a weight of 0.01 % on Dec 29, 2023 and 0.01 % on Sep 18, 2026. Its share peaked at 0.01 % on Dec 29, 2023. The weight rises and falls with the stock's price relative to the other index members, and it also shifts when the index provider changes the composition.
How much Jamjoom Pharma overlaps with other holdings in a portfolio is shown by the What's Inside Your ETF Portfolio and the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as Jamjoom Pharma — the figure counts the ETFs holding both.
| Stock | Ticker | Shared ETFs | r |
|---|---|---|---|
| Saudi Pharmaceutical Indust and Me | 2070 | 1 | – |
| Al Mouwasat Medical Services | 4002 | 1 | – |
| DR Soliman Abdel Kader Fakeeh | 4017 | 1 | – |
| Shandong Weigao GP Medical Polymer | 1066 | 1 | – |
| Hanmi Pharm Ltd. | 128940 | 1 | – |
| Liga Chem Bio Inc. | 141080 | 1 | – |
| Jinxin Fertility Group | 1951 | 1 | – |
| Ssy Group Ltd. | 2005 | 1 | – |
